Gisela Paulsen serves as Executive at Oncocyte Corp, where they oversee executive responsibilities. Since joining the company, Gisela Paulsen has executed 4 insider transactions totaling $19.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 1, 2022 involved selling 175,000 shares valued at $0.
Gisela Paulsen currently holds 366,500 shares of Oncocyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gisela Paulsen has been a net buyer of OCX stock. They have purchased $19.8K and sold $0 worth of shares.
Gisela Paulsen's most recent insider trade was on Dec 1, 2022, when they sold 175,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 15, 2022 | OCX | $0 | Award | 350,000 | $N/A | Discretionary |
| Mar 17, 2022 | OCX | $19.8K | Purchase | 16,500 | $1.20 | Discretionary |